ClinicalTrials.Veeva

Menu

Feasibility Study of Barrier Enhancement for Eczema Prevention (BEEP)

Oregon Health & Science University (OHSU) logo

Oregon Health & Science University (OHSU)

Status

Unknown

Conditions

Eczema

Treatments

Drug: Control group
Drug: Cetaphil cream
Drug: Aquaphor ointment
Drug: Sunflower oil

Study type

Interventional

Funder types

Other

Identifiers

Details and patient eligibility

About

The purpose of this protocol is to determine the feasibility of doing larger follow-up studies examining whether emollients used from birth can prevent eczema in high-risk babies and to help investigators find out if emollients (moisturizing skin creams) used from birth can prevent eczema in high-risk babies. Hypothesis: Enhancing the skin barrier from birth using emollients will prevent or delay the onset of eczema, especially in predisposed infants.

Enrollment

46 patients

Sex

All

Ages

1 minute to 6 months old

Volunteers

No Healthy Volunteers

Inclusion criteria

  1. Participant must have a parent or sibling with a history of at least one of the following: eczema, allergic rhinitis or asthma
  2. Infant in overall good health
  3. Mother between the ages of 16 and 45 years of age at delivery; infant from birth thru 6 months of age
  4. Capable of giving informed consent

Exclusion criteria

  1. Preterm birth defined as birth prior to 37 weeks gestation
  2. Major congenital anomaly
  3. Hydrops fetalis
  4. Significant dermatitis at birth not including seborrheic dermatitis ("cradle cap")
  5. Any immunodeficiency disorder or severe genetic skin disorder
  6. Any other serious condition that would make the use of emollients inadvisable
  7. Any other major medical problems that the investigator deems may increase the risk of adverse events with the intervention

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Single Blind

46 participants in 2 patient groups

Intervention (moisturizer group)
Active Comparator group
Description:
One group will be instructed to use a choice of 3 FDA-approved moisturizers and soap substitutes on their newborn infants.
Treatment:
Drug: Cetaphil cream
Drug: Sunflower oil
Drug: Aquaphor ointment
Control group (no moisturizers)
Active Comparator group
Description:
This group will be asked NOT to use any skin moisturizers and use only soap substitutes on their infants.
Treatment:
Drug: Control group

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems